Pharmaceutical Commerce - April 2022 Issue (PDF)

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.

Renier Brentjens, MD, PhD outlines the evolution of the space, while offering ways to boost patient access to these treatments.

A survey study takes a closer look into which medications patients would like to have deprescribed, along with the reasons and factors influencing that decision.